Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 833 of 1,261
  1. US 8637457

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  2. US 8637074

    Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product

    Aphios Corporation · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  3. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  4. US 8637511

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  5. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  6. US 8637503

    Phenothiazine enantiomers as agents for the prevention of bone loss

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  7. US 8637079

    Solid preparation comprising alogliptin and pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  8. US 8637011

    Modulation of NKG2D

    The Regents of the University of California · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  9. US 8636978

    Cyclized NGR peptide compounds, compositions, and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  10. US 8636994

    Polymer-based compositions and conjugates of antimicrobial agents

    Nektar Therapeutics · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  11. US 8637013

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  12. US 8637561

    Linked diimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  13. US 8633210

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  14. US 8633277

    Methods for forming polymer-drug conjugates

    Nektar Therapeutics · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  15. US 8633177

    Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  16. US 8633189

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  17. US 8633034

    Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution

    The Regents of the University of Colorado · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  18. US 8633205

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  19. US 8633178

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  20. US 8632839

    Methods of forming self-supporting films for delivery of therapeutic agents

    Covidien LP · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  21. US 8633019

    Methods for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  22. US 8632808

    Taste-masking solid preparation of pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  23. US 8633154

    Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  24. US 8632510

    Nanochanneled device and related methods

    The Board of Regents of the University of Texas System · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.